GFR Pharmaceuticals Inc. (GFRP) Financials Nov 13, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for GFR Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 3.68M 3.88M 4.36M 4.67M 4.27M
Cost of Goods Sold (COGS) incl. D&A 929,021 1.07M 894,333 1.46M 1.78M
COGS excluding D&A 268,278 474,724 120,935 614,530 172,496
Depreciation & Amortization Expense 660,743 596,988 773,398 844,305 1.61M
Depreciation 660,743 596,988 - - -
Amortization of Intangibles - 0 0 0 0
Gross Income 2.75M 2.81M 3.47M 3.22M 2.49M
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 5.71M 1.08M 500,405 485,196 700,422
Research & Development - - - 29,145 103,138
Other SG&A 5.71M 1.08M 500,405 456,051 597,284
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 555,886 0 0 0 0
Non-Operating Interest Income 47,263 17,051 1,614 1,510 2,013
Equity in Affiliates (Pretax) 0 0 255,947 0 0
Interest Expense 121,433 0 0 - -
Gross Interest Expense 121,433 0 0 - -
Interest Capitalized 0 0 0 0 0
Pretax Income (2.48M) 1.75M 3.22M 2.73M 1.79M
Income Tax 628,747 571,643 688,045 674,421 459,853
Income Tax - Current Domestic - - - 0 -
Income Tax - Current Foreign - - - 674,421 -
Income Tax - Deferred Domestic - - - 0 0
Income Tax - Deferred Foreign - - - 0 0
Income Tax Credits - - - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - - 0
Consolidated Net Income (3.11M) 1.18M 2.54M 2.06M 1.34M
Minority Interest Expense (71,949) 79,778 90,624 86,497 57,905
Net Income (3.04M) 1.1M 2.45M 1.97M 1.28M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.04M) 1.1M 2.45M 1.97M 1.28M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (3.04M) 1.1M 2.45M 1.97M 1.28M
EPS (Basic) (0.07) 0.03 0.06 0.05 0.03
Basic Shares Outstanding 42.08M 42.08M 42.08M 42.08M 42.08M
EPS (Diluted) (0.07) 0.03 0.06 0.05 0.03
Diluted Shares Outstanding 42.08M 42.08M 42.08M 42.08M 42.08M
EBITDA (2.31M) 2.33M 3.74M 3.57M 3.4M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for GFR Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 3.68M 3.88M 4.36M 4.67M 4.27M
Cost of Goods Sold (COGS) incl. D&A 929,021 1.07M 894,333 1.46M 1.78M
COGS excluding D&A 268,278 474,724 120,935 614,530 172,496
Depreciation & Amortization Expense 660,743 596,988 773,398 844,305 1.61M
Depreciation 660,743 596,988 - - -
Amortization of Intangibles - 0 0 0 0
Gross Income 2.75M 2.81M 3.47M 3.22M 2.49M
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 5.71M 1.08M 500,405 485,196 700,422
Research & Development - - - 29,145 103,138
Other SG&A 5.71M 1.08M 500,405 456,051 597,284
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 555,886 0 0 0 0
Non-Operating Interest Income 47,263 17,051 1,614 1,510 2,013
Equity in Affiliates (Pretax) 0 0 255,947 0 0
Interest Expense 121,433 0 0 - -
Gross Interest Expense 121,433 0 0 - -
Interest Capitalized 0 0 0 0 0
Pretax Income (2.48M) 1.75M 3.22M 2.73M 1.79M
Income Tax 628,747 571,643 688,045 674,421 459,853
Income Tax - Current Domestic - - - 0 -
Income Tax - Current Foreign - - - 674,421 -
Income Tax - Deferred Domestic - - - 0 0
Income Tax - Deferred Foreign - - - 0 0
Income Tax Credits - - - 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - - 0
Consolidated Net Income (3.11M) 1.18M 2.54M 2.06M 1.34M
Minority Interest Expense (71,949) 79,778 90,624 86,497 57,905
Net Income (3.04M) 1.1M 2.45M 1.97M 1.28M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.04M) 1.1M 2.45M 1.97M 1.28M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (3.04M) 1.1M 2.45M 1.97M 1.28M
EPS (Basic) (0.07) 0.03 0.06 0.05 0.03
Basic Shares Outstanding 42.08M 42.08M 42.08M 42.08M 42.08M
EPS (Diluted) (0.07) 0.03 0.06 0.05 0.03
Diluted Shares Outstanding 42.08M 42.08M 42.08M 42.08M 42.08M
EBITDA (2.31M) 2.33M 3.74M 3.57M 3.4M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
